| For: | Chai SY, Zhang RY, Fernandes G, Zheng YM, Wei L. Epidemiology of metabolic dysfunction-associated steatotic liver disease/metabolic dysfunction-associated steatohepatitis and associated cardiometabolic factors in adults in China (2013-2023): A systematic review and meta-analysis. World J Gastroenterol 2025; 31(46): 113608 [PMID: 41479652 DOI: 10.3748/wjg.v31.i46.113608] |
|---|---|
| URL: | https://www.wjgnet.com/1007-9327/full/v31/i46/113608.htm |
| Number | Citing Articles |
| 1 |
Hailong Zhang, Zhuoru Jiang, Huanhuan Zheng, Haoyao Wang, Liankun Xia, Jun Chen, Bing Zhang. Liver CT-based composite biomarkers can identify MASH and steatosis grade in people with obesity prior to bariatric surgery: a retrospective study. BMC Gastroenterology 2026; 26(1) doi: 10.1186/s12876-026-04914-2
|
| 2 |
Yaoyao Chen, Shangcheng Xu, Tao Sun. The liver-brain axis, from its function to preventive therapeutic strategies in diseases. Frontiers in Endocrinology 2026; 17 doi: 10.3389/fendo.2026.1858091
|
| 3 |
Luyao Xu, Qiuling Li, Chengqin Lu, Mincheng Zheng, Wenhai Guo, Yun Chen, Jiaying Dai, Yao Deng, Ning Zhang, Kanlin Yang, Xinling Chen, Kangrong Wang, Guohang Yan, Hantao Li, Rui Duan, Jiean Xu, Wei Liu, Hongzhi Yang, Jinwen Xu, Min Dai, Yaxing Zhang. Tao-Hong-Si-Wu-Tang protects against methionine- and choline-deficient diet-induced hepatic steatosis in rats and is associated with inhibition of oxidative stress, inflammation, apoptosis, and pyroptosis. Frontiers in Immunology 2026; 17 doi: 10.3389/fimmu.2026.1767119
|
| 4 |
Mirjana Grocic, Madison Nguyen, Arun J. Sanyal. Current Trends in the Epidemiology of Obesity and the Association Between Obesity and Metabolic Liver Disease (MASLD/MASH). Diabetes, Obesity and Metabolism 2026; 28(S2) doi: 10.1111/dom.70662
|